Provention Bio Inc (PRVB) Return on Investment ROI from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Provention Bio Inc   (NASDAQ: PRVB)


Provention Bio Inc's ROI from its fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Provention Bio Inc's ROI in the fourth quarter of 2022?
Provention Bio Inc recorded a cumulative net loss of $-114 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on investment (ROI) of -92.73%.

Within the Healthcare sector 928 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2022 from 0 to 5237.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Investment Change TTM -17.75 % -23.27 % -28.4 % -15.72 % 23.52 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 146 169 79 95 113
Return On Investment (TTM) -92.73 % -93.04 % -98.47 % -82.51 % -76.85 %
PRVB's Overall Ranking # 5237 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 7.37 % 7.47 % -15.77 % -15.38 % 0.18 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -114 -106 -105 -104 -114

PRVB Company Profile >> Back to PRVB Roi Comparisons >> See Annual PRVB Return On Investment



Return On Investment PRVB's Ranking
Within: No.
Industry # 438
Sector # 929
Overall # 5237

Return On Investment Statistics
High Average Low
-53.86 %
-105 %
-447.48 %
(Jun 30 2020)   (Jun 30 2018)







Financial Statements
Provention Bio Inc's IV. Quarter Investments $ 146 Millions PRVB's Balance sheet
Provention Bio Inc's IV. Quarter Income $ -33 Millions Quarterly PRVB's Income Statement
PRVB's Income by Division See PRVB's Income by Division


PRVB Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 146 113 112 82 60
Y / Y Investment Growth 29.81 % 0.93 % 36.07 % 37.71 % -
Net Income in Millions -114 -114 -99 -43 -26
Y / Y Net Income Growth - - - - -
Annual Return On Investment -77.54 % -101.42 % -88.18 % -52.69 % -44.38 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PRVB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PRVB's Competitors
Subscribers only: Roi for Provention Bio Inc's Suppliers
Subscribers only: Return On Investment for PRVB's Customers

Other Ratios
PRVB's Roa PRVB's Inventory Turnover Ratio PRVB's Growth Rates PRVB's Dividend Statistics
PRVB's Profitability Ratios PRVB's Asset Turnover Ratio PRVB's Dividend Growth
PRVB's Roe PRVB's Valuation Ratios PRVB's Financial Strength Ratios PRVB's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.